The US mass spectrometry market is expanding through strong demand from pharmaceutical development, biotechnology research, clinical diagnostics, and environmental analysis. Increasing use of high-resolution and LC-MS platforms for biomarker identification, drug characterization, therapeutic monitoring, and complex sample analysis is encouraging laboratories to upgrade their analytical...